title: Plasma apolipoprotein A-IV metabolism in patients with chronic renal disease.
abstract: The plasma concentration and distribution of apolipoprotein A-IV were investigated in normotriglyceridaemic patients with end-stage renal disease and compared with those in a sex- and age-matched control group with normal renal function. A three-fold elevated plasma mean concentration of apolipoprotein A-IV was found in patients with end-stage renal disease treated by haemo- or peritoneal dialysis (58.5 +/- 18.9 mg dl-1 or 50.5 +/- 12.2 mg dl-1, respectively) compared with the controls (18.3 +/- 6.4 mg dl-1). The plasma distribution of apolipoprotein A-IV was studied in patients treated by haemodialysis and in controls by gel permeation chromatography. In the haemodialysis group, 40.3% of the apolipoprotein A-IV was found to be associated with the fraction of high density lipoproteins, whereas the rest (59.7%) was not associated with lipoproteins. This distribution was significantly different from that in the control group (24.8% vs. 75.2%, 0.01 less than P less than 0.05). The elevated plasma concentrations of apolipoprotein A-IV in the patients are not related to triglyceride levels and therefore are unlikely to result from an impaired catabolism of triglyceride-rich lipoproteins. The accumulation of apolipoprotein A-IV in high density lipoproteins from patients with end-stage renal disease might reflect the impaired reversed cholesterol transport mechanisms which are believed to be a major cause of the high prevalence of atherosclerotic diseases in these patients.
authors.affiliation: Institute of Medical Biology and Human Genetics, University of Innsbruck, Austria.
authors.forename: H
authors.initials: H
authors.lastname: Dieplinger
authors.forename: E M
authors.initials: EM
authors.lastname: Lobentanz
authors.forename: P
authors.initials: P
authors.lastname: König
authors.forename: H
authors.initials: H
authors.lastname: Graf
authors.forename: C
authors.initials: C
authors.lastname: Sandholzer
authors.forename: E
authors.initials: E
authors.lastname: Matthys
authors.forename: M
authors.initials: M
authors.lastname: Rosseneu
authors.forename: G
authors.initials: G
authors.lastname: Utermann
mesh_terms: D000328:Adult; D000368:Aged; D001053:Apolipoproteins / Q000097:blood; D001054:Apolipoproteins A / Q000378:metabolism*; D005260:Female; D006801:Humans; D007668:Kidney / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000378:metabolism / Q000628:therapy; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D006435:Renal Dialysis
chemical_list: D001053:Apolipoproteins; D001054:Apolipoproteins A; D008055:Lipids; C022205:apolipoprotein A-IV